News on OGT from BioPortfolio.com http://www.BioPortfolio.com Consolidated OGT news from BioPortfolio.com Wed, 10 Feb 2010 13:28:33 GMT en OGT Plans to Put New Consortium-Designed Arrays 'Forward First' to Cyto Customershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037765&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037765&THISHREF=http://c.moreover.com/click/here.pl%3fz2537276033%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037765&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037765&THISHREF=http://c.moreover.com/click/here.pl%3fz2537276033%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: OGT introduces CytoSure aCGH arrays for detecting disease, syndrome-related aberrationshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029153&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029153&THISHREF=http://c.moreover.com/click/here.pl%3fz2533008792%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029153&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029153&THISHREF=http://c.moreover.com/click/here.pl%3fz2533008792%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: OGT Launches New ISCA-Endorsed CytoSure aCGH Arrays for Detecting Disease and Syndrome-Related Aberrationshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006883&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006883&THISHREF=http://c.moreover.com/click/here.pl%3fz2520902910%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006883&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006883&THISHREF=http://c.moreover.com/click/here.pl%3fz2520902910%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSelect Science: OGT Launches New ISCA-Endorsed Cytosure Acgh Arrays For Detecting Disease And Syndrome-Related Aberrationshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003172&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003172&THISHREF=http://c.moreover.com/click/here.pl%3fz2519334945%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003172&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003172&THISHREF=http://c.moreover.com/click/here.pl%3fz2519334945%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioresearch Online: Zavesca (miglustat) receives positive vote from the FDA's Endocrinologic and Metabolic Drugs Advisory Committehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3913380&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3913380&THISHREF=http://c.moreover.com/click/here.pl%3fz2470637845%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3913380&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3913380&THISHREF=http://c.moreover.com/click/here.pl%3fz2470637845%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Zavesca receives positive vote from FDA for the treatment of Niemann-Pick type C diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912446&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912446&THISHREF=http://c.moreover.com/click/here.pl%3fz2470220286%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912446&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912446&THISHREF=http://c.moreover.com/click/here.pl%3fz2470220286%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: FDA Advisory Committee Recommends Expanding Miglustat Use to Niemann-Pick Disease Type Chttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905199&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905199&THISHREF=http://c.moreover.com/click/here.pl%3fz2466093038%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905199&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905199&THISHREF=http://c.moreover.com/click/here.pl%3fz2466093038%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology Healthcare: 1/13/10 - FDA recommends approval of Actelion's Zavescahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904893&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904893&THISHREF=http://c.moreover.com/click/here.pl%3fz2465907993%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904893&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904893&THISHREF=http://c.moreover.com/click/here.pl%3fz2465907993%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: FDA recommends approval of Actelion's Zavescahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904617&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904617&THISHREF=http://c.moreover.com/click/here.pl%3fz2465756547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904617&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904617&THISHREF=http://c.moreover.com/click/here.pl%3fz2465756547%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Lab901 delivers first Next-generation RNA QC ScreenTape System to Oxford Gene Technologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903895&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903895&THISHREF=http://c.moreover.com/click/here.pl%3fz2465434205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903895&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903895&THISHREF=http://c.moreover.com/click/here.pl%3fz2465434205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Zavesca (miglustat) receives positive vote from the FDA's Endocrinologic and Metabolic Drugs Advisory Committee for the treatment of Niemann-Pick type C diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897134&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897134&THISHREF=http://c.moreover.com/click/here.pl%3fz2462107544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897134&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897134&THISHREF=http://c.moreover.com/click/here.pl%3fz2462107544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: OGT Implements Lab901's ScreenTape System for RNA QChttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889625&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889625&THISHREF=http://c.moreover.com/click/here.pl%3fz2458837741%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889625&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889625&THISHREF=http://c.moreover.com/click/here.pl%3fz2458837741%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: US Food and Drug Administration grants priority review for Actelion's miglustat in Niemann-Pick type C diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3662527&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3662527&THISHREF=http://c.moreover.com/click/here.pl%3fz2345149457%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3662527&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=OGT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3662527&THISHREF=http://c.moreover.com/click/here.pl%3fz2345149457%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: